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Objective. Vitamin D deﬁciency is associated with a variety of skeletal and extraskeletal problems. The aim of this study was to
evaluate the prevalence of vitamin D deﬁciency among veterans in sunny Louisiana. Methods. Using the VA computerized patient
recordsystem,wesearchedforall25(OH)VitaminDand1,25(OH)vitaminDlevelsthatweremeasuredbetween2007and2009.
The information collected for each patient included age, body mass index, creatinine, history of diabetes and hypertension, and
levels of vitamin D and PTH. We determined the number of individuals who were vitamin D insuﬃcient and deﬁcient. Results.
Among 2990 studies evaluated, the mean concentration of 25 (OH) D was 22.5±0.2ng/mL, and that of 1, 25 (OH) vitamin D was
29.2 ± 0.4ng/mL. Among them, only 695 subjects (23%) had normal values, while 889 (30%) had insuﬃciency, and 1405 (47%)
had deﬁciency. Subjects with diabetes (1041) had signiﬁcantly (P<0.0001) lower levels (21 and 25ng/mL) of both 25 (OH) and
1,25 (OH) vitamin D compared to subjects without diabetes (23 and 32ng/mL). Similarly, subjects with chronic kidney disease
(1128) had much lower vitamin D levels than subjects without CKD. Among subjects with diabetes, those with chronic kidney
disease (512) had much lower levels of both 25 (OH) and 1,25 (OH) vitamin D than with those with normal creatinine levels.
Conclusions. We conclude that vitamin D insuﬃciency and deﬁciency is highly prevalent in veterans, more so among subjects with
diabetes and/or CKD.
1.Introduction
Vitamin D is an essential nutrient and is known for its role
in calcium homeostasis, which is vital for optimal skeletal
health. Epidemiological studies suggest a higher prevalence
of metabolic syndrome and its components among individ-
uals with vitamin D deﬁciency. The best marker of vitamin
D status is the serum 25-hydroxyvitamin D concentration
[1]. The 25-hydroxyvitamin D level should be measured in
patients with suspected vitamin D deﬁciency. Many factors
inﬂuence circulating 25-hydroxyvitamin D levels including
race, season, body mass index, and age [1]. Vitamin D deﬁ-
ciency can cause osteomalacia, rickets, and myopathy and is
associated with a variety of extraskeletal problems, including
cardiovascular disease, infection, malignancy, and death [1–
3]. Humans get vitamin D from exposure to sunlight, from
theirdiets,andfromdietarysupplements.Calciumisactively
absorbed from the small intestine in the presence of vitamin
D. Vitamin D refers to vitamin D2 (ergocalciferol)or vitamin
D3 (cholecalciferol). Vitamin D deﬁciency is deﬁned as a
serum 25-hydroxyvitamin D level of less than 20ng/mL
(50nmol/L), and insuﬃciency is deﬁned as a serum 25-
hydroxyvitamin D level of 20 to 30ng/mL (50 to 75nmol/L).
McMurtry and colleagues found that most veterans living
in nursing homes suﬀer from vitamin D insuﬃciency [4].
There is limited literature concerning the prevalence of
compromised vitamin D status among veterans. The aim
of this study is to evaluate the prevalence of vitamin D
deﬁciency in subjects with type 2 diabetes and/or chronic
kidney disease among veterans living in sunny Louisiana.
2. Methods
T h i ss t u d yi sar e t r o s p e c t i v es t u d yf r o mO v e r t o nB r o o k s
Veterans Administration Medical Center (VAMC) in Shreve-















CKD versus No CKD
Figure 1: Shows the parameters in subjects with or without CKD.
CKD: chronic kidney disease; DM: diabetes; HTN: hypertension;
PTH: parathyroid hormone; GFR: glomerular ﬁltration Rate.
Institutional Review Board (IRB) for Ethical Research at
LSUHSC and the Research and Development (R&D) Board
at VAMC committees, as well as approval for the database
retrieval by the regional administration (VISN), we used the
database of the Veterans Health Administration (VHA) to
retrieve data from the computerized patient record system
(CPRS) records for patients seen between 2007 and 2008. We
retrievedall25-hydroxyvitaminDand1,25(OH)2 vitaminD
levelsthatweremeasuredbetween2007and2008,alongwith
the clinical and demographic information, and limited lab-
oratory data, for the subjects associated with those vitamin
D levels. Data collected include age, sex, body mass index
(BMI), diagnosis of type 2 diabetes, hypertension, insulin
use, hemoglobin A1C, calculated glomerular ﬁltration rate
(eGFR), calcium, creatinine, parathyroid hormone (PTH),
and 25-hydroxyvitamin D and 1,25 (OH)2 vitamin D levels.
The data were analyzed to compare subjects with or without
diabetes. Similarly the data was compared among the groups
with or without chronic kidney disease (CKD). Among
subjects with diabetes, comparison was again carried out
among subjects with or without CKD.
2.1. Statistical Analysis.T h ed a t ai se x p r e s s e da sm e a n±stan-
dard deviation.
3. Results
Data were collected from 2990 subjects. Most of the study
subjects included were more than 60 years old. Seventy-
seven percent of subjects had 25 (OH) vitamin D levels lower
than 30ng/mL and 47% had levels lower than 20ng/mL.
Thirty-ﬁve percent (1041) of subjects had diabetes and 38%
(1128) had CKD (Figure 1). Subjects with diabetes (1041)
had signiﬁcantly lower levels of both 25 and 1,25 (OH)2
vitamin D. The clinical and laboratory data for subjects with
or without diabetes are shown in Table 1. Similarly, subjects
with CKD had signiﬁcantly lower levels of both 25 and 1,25
(OH)2 vitamin D. The data for subjects with or without
CKD are shown in Table 2.S u b j e c t sw i t hC K Dw e r eo l d e r
and had a higher prevalence of hypertension compared to
those without CKD. Among subjects with diabetes, subjects
with CKD had markedly decreased levels of both 25 and
Table 1: Shows clinical and laboratory parameters comparing
groups with or without diabetes. Data expressed as ±SD; DM:
group with type 2 diabetes; No DM: group without type 2 diabetes;
BMI: body mass index; HTN: hypertension; GFR: glomerular
ﬁltration rate; PTH: parathyroid hormone.
Diabetes versus no diabetes
DM No DM P-Value
Age in years 69 ±0.34 68 ± 0.32 0.01152
BMI 31 ±0.22 7 .3 ±0.31 . 7 4 E−43
HTN (%) 88 59 2.76E−38
Creatinine 1.91 ±0.05 1.52 ±0.03 2.15E−09
Glucose 154 ±2.5 106 ±0.58 . 2 2 E−63
GFR 56 ±0.96 7 ±0.62 1.18E−20
Calcium 9.2 ±0.02 9.3 ±0.01 0.022327
25 (OH) vit D 21 ±0.34 23 ±0.25 6.55E−08
1,25 vit D 25.5 ±0.67 32.6 ±0.65 8.81E−14
Intact PTH 105 ± 4.99 2 ±0.36 0.032545
1,25 (OH)2 vitamin D. Relative PTH levels were higher in
all groups. PTH levels were elevated in relation to creatinine
and declining eGFR. The comparative data of subjects with
or without CKD among subjects with type 2 diabetes are
shown in Table 3. The levels of 1,25 (OH)2 vitamin D levels
correlated positively with eGFR (r = 0.34; P<0.0001)
and negative correlation with creatinine (r =−0.26; P<
0.0001). There was a weak positive correlation of 25 (OH)
vitamin D levels to eGFR (r = 0.10; P<0.001) and
negatively with creatinine (r =−0.10; P<0.001), although
the latter was statistically signiﬁcant (Table 4).
4. Discussion
Vitamin D inﬂuences many physiological processes besides
calcium/phosphate homeostasis, including muscle and ker-
atinocyte diﬀerentiation, insulin secretion, blood pressure
regulation, and the immune response [1, 5, 6]. Classical
roles of vitamin D include the regulation of blood calcium
and phosphate concentrations by actions in the intestine,
bone, parathyroid, and kidney. Nonclassical roles include
cell diﬀerentiation and antiproliferative actions in various
cell types, including bone marrow (osteoclast precursors
and lymphocytes), immune system, skin, breast, prostate
epithelial cells, muscle, and intestine [5].
The data collected for the study were from male veterans
residing in sunny North West Louisiana, which is rich in
sunlight almost year long. It was obvious that they had
been exposed to less sunlight despite the fact that they live
in a region that is sunny most of the year. In general, the
study population was older, with a mean age of 68 years,
and most subjects had BMIs in the overweight or obese
range. In this study, we used the cut-oﬀ level 75nmol/L
to deﬁne vitamin D deﬁciency, and we found a prevalence
of 77%. Since the BMI of our patient population was
generally>27kg/m2,itisunlikelythatpoornutritionalstatus
caused these deﬁciencies. The inverse association between
25(OH) D and metabolic syndrome found in our study isISRN Endocrinology 3
Table 2: Shows clinical and laboratory parameters in groups
comparing with or without CKD. Data expressed as ±SD; DM: type
2 diabetes; CKD: chronic kidney disease; HTN: hypertension; BMI:
body mass index; GFR: glomerular ﬁltration rate; PTH: parathyroid
hormone; Cre: creatinine.
CKD versus No CKD
No CKD CKD P-Value
Age 66.6 ±0.31 68 ±0.32 1.16E−23
BMI 28.4 ±0.22 8 .9 ±0.2 0.052549
DM (%) 28 45 1.94E−20
HTN (%) 70 85 1.65E−23
Insulin use (%) 8 21 5.95E−21
Cre 1.04 ±0.04 2.72 ±0.07 8.7E−102
Glucose 119 ±1.1 133 ±2.25 1.11E−08
GFR 79 ±0.49 36 ±0.51 0
Calcium 9.3 ±0.01 9.2 ±0.01 0.000191
25 (OH) vit 23 ±0.26 21 ±0.33 3.77E−07
1,25 vit D 36 ± 0.82 4 ±0.54 . 9 4 E−30
HbA1C 6.4 ±0.03 6.6 ±0.05 0.003844
Intact PTH 61 ± 2.1 122 ±4.52 . 2 1 E−31
consistent with that reported in the studies in the literature
[7, 8]. Theoretically, it could be explained as the result
of vitamin D deposition in body lipids and subsequently
reduced bioavailability of vitamin D3 from skin [9]. Our
study results, which show an association between vitamin D
anddiabetes,aresimilartothosefromanumberofpublished
studies. The sun is the primary source of vitamin D. It is
synthesized endogenously in skin to produce cholecalciferol
(vitamin D3), although a small proportion (20%) of vitamin
D comes from diet [10]. The marker of vitamin D status
is 25-hydroxyvitamin D [25(OH)D] levels. Blood levels of
25(OH)D decline with age and obesity. It is postulated that
blood levels of 25(OH)D inverse to those of diabetes reﬂect
the prevalence of vitamin D deﬁciency, which increases
with age and obesity [11]. Several studies have reported an
associationbetweenvitaminDdeﬁciencyanddiabetes.More
than a decade ago, the inverse correlation of vitamin D to
blood glucose levels was reported [12, 13]. The discovery of a
nonclassical pathway (which is also present in renal tissue)
has brought new signiﬁcance to the nutritional vitamin
D deﬁciency, given the potential role that hypovitaminosis
D may play in multiple chronic diseases such as diabetes,
chronic infectious processes, hypertension, cardiovascular
disease, and CKD [5].
Our data in patients with CKD is not surprising. Despite
guidelines suggesting vitamin D supplementation in CKD
patients, we still noted signiﬁcant vitamin D deﬁciencies.
Patients with CKD have an exceptionally high rate of severe
vitamin D deﬁciency that is further exacerbated by their
reduced ability to convert 25-(OH) vitamin D into the
active form, 1,25 dihydroxy-vitamin D. In patients with any
stage of chronic kidney disease, 25-hydroxyvitamin D should
be measured annually, and the level should be maintained
at 30ng per milliliter or higher, as recommended in the
Kidney Disease Outcomes Quality Initiative guidelines from
Table 3: Shows clinical and laboratory parameters in subjects with
diabetes compared with or without chronic kidney disease. Data
expressed as ± SD; DM: type 2 diabetes; CKD: chronic kidney dis-
ease; BMI: body mass index; HTN: hypertension; GFR: glomerular
ﬁltration rate; PTH: parathyroid hormone, Cre: creatinine.
Subjects with diabetes with or without CKD
NO CKD CKD P-Value
Age 67 ±0.57 1 ±0.46 0.01152
BMI 30 ±0.33 1 ±0.31 . 7 4 E−43
HTN (%) 85 91 2.76E−38
Insulin Use (%) 28 46 3.6E−106
Cre 1.06 ±0.01 2.8 ±0.09 2.15E−09
Glucose 149 ±2.9 157 ±48 . 2 2 E−63
GFR 77 ±0.93 5 ±0.73 1.18E−20
Calcium 9.3 ±0.02 9.2 ±0.02 0.022327
25 (OH) vit 22.3 ±0.47 19.6 ±0.49 6.55E−08
1,25 vit D 31.9 ±1.22 2 .9 ±0.75 8.81E−14
HbA1C 6.9 ±0.05 6.8 ±0.06 2.65E−89
Intact PTH 63 ±0.3 124 ±0.60 .032545
Table 4: Shows clinical and laboratory parameters in subjects with
normal creatinine with or without DM. Data expressed as ±SD;
DM: type 2 diabetes; BMI: body mass index; HTN: hypertension;
GFR: glomerular ﬁltration rate; PTH: parathyroid hormone; Cre:
creatinine.
No DM DM P value
Age 67 ±0.46 8 ± 0.4 <.0001
BMI 27 ±0.17 31 ±0.27 <.0001
HTN (%) 67 86 <.0001
Cre 1.05 1.1 <.001
Glucose 105 149 <.0001
GFR 78 ±0.56 74 ±0.95 <.0001
Calcium 9.3 9.2 NS
25 (OH) vitamin D 23.7 ±0.30 22.3 ±0.45 <.0001
1,25 vit D 37.4 ±0.94 31.9 ±1.17 <.0001
Intact PTH 61.7 ±2.46 5 .1 ±3.5N S
the National Kidney Foundation [6]. CKD patients often
display vitamin D insuﬃciency as evidenced by insuﬃcient
circulating 25-OH-D (all stages of CKD) and progressive
“circulating” 1 α,25-(OH)2D3 deﬁciency with the loss of
renal 1α-hydroxylase (Stages 3–5 of CKD). Subjects under-
going chronic hemodialysis have been shown to have a
signiﬁcant survival advantage when given vitamin D therapy.
Since both CKD and diabetes are associated with vitamin
D deﬁciency, the profoundly low vitamin D levels measured
in subjects with diabetes, and CKD may be secondary to an
additive eﬀect of both disease conditions.
4.1. Draw Backs. As the study is a retrospective study, vita-
min D supplementation details are not available.4 ISRN Endocrinology
5. Conclusions
The prevalence of vitamin D deﬁciency in the study popula-
tion is quite high, especially in subjects with diabetes and/or
CKD. The prevalence is higher in subjects with CKD with
diabetes than in subjects with CKD without diabetes. We
recommend increased sun exposure and additional vitamin
D in the form of increased dietary supplementation to
achieve a vitamin D suﬃcient state in both type 2 diabetes
and CKD.
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